Literature DB >> 171953

Hepatitis in marmosets.

F Deinhardt, D Peterson, G Cross, L Wolfe, A W Holmes.   

Abstract

Some species of marmosets are susceptible, not only by parenteral inoculation but also by oral exposure, to human hepatitis A virus present in sera or feces. The stools of animals inoculated parenterally or orally contained fecal antigen during certain times of the incubation period and the early, acute phase of the disease; viruslike particles were present in feces of orally infected animals and such feces were infectious when inoculated into marmosets. The fecal antigen crossreacted both with the fecal virus particles and the immune-adherence antigen (see also papers by Purcell et al and Hilleman et al). The MS-1 and CR-326 strains of hepatitis A appeared antigenically similar or identical whereas the GB strain was antigenically different and may be associated with the recently defined type of hepatitis termed hepatitis C or hepatitis non-A/non-B. On repeated challenge hyperegic responses with diffuse liver cell necrosis occurred in some immune animals and this phenomenon must be taken into account in any future vaccination studies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171953     DOI: 10.1097/00000441-197507000-00011

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  13 in total

1.  Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.

Authors:  Cordelia Manickam; Premeela Rajakumar; Lynn Wachtman; Joshua A Kramer; Amanda J Martinot; Valerie Varner; Luis D Giavedoni; R Keith Reeves
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Immune function in marmosets. Present state of relevant knowledge.

Authors:  D R Johnson
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

3.  Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis.

Authors:  A S Muerhoff; T P Leary; J N Simons; T J Pilot-Matias; G J Dawson; J C Erker; M L Chalmers; G G Schlauder; S M Desai; I K Mushahwar
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Propagation of human hepatitis A virus in a hepatoma cell line.

Authors:  G G Frösner; F Deinhardt; R Scheid; V Gauss-Müller; N Holmes; V Messelberger; G Siegl; J J Alexander
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.

Authors:  E A Brown; R W Jansen; S M Lemon
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Purification of hepatitis A virus from chimpanzee stools.

Authors:  D W Bradley; C L Hornbeck; E H Cook; J E Maynard
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

7.  Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulence.

Authors:  G Raychaudhuri; S Govindarajan; M Shapiro; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Fatal measles infection in marmosets pathogenesis and prophylaxis.

Authors:  P Albrecht; D Lorenz; M J Klutch; J H Vickers; F A Ennis
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

9.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Glomerulonephritis associated with arteritis in marmosets infected with hepatitis A virus.

Authors:  M Morita; K Kitajima; H Yoshizawa; Y Itoh; S Iwakiri; C Shibata; M Mayumi
Journal:  Br J Exp Pathol       Date:  1981-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.